ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Cancer Information Service Marks 20th anniversary

April 4, 1996

Letter to the Editor: Expanding the Horizons Of Proton Beam Therapy

August 1, 2014

GSK HPV Vaccine Offers Protection From 4 HPV Types

April 27, 2007

New CCOP RFA Available; Briefing At ASCO Jammed

June 2, 1989

NCI Awards 12 Grants For Planning of New Cancer Centers

March 27, 1992

RPR Grant To NABCO Does Not Support Advocacy, Firm Says

November 10, 1995